시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
전신 마취제 시장 규모, 점유율, 성장 분석 : 약물 유형별, 투여 경로별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)
General Anesthesia Drugs Market Size, Share, Growth Analysis, By Drug Type (Propofol, Sevoflurane), By Route of Administration (Intravenous, Inhaled), By End-Use, By Application, By Region - Industry Forecast 2025-2032
상품코드 : 1622414
리서치사 : SkyQuest
발행일 : 2024년 12월
페이지 정보 : 영문 260 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,652,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,951,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,250,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

전신 마취제 시장 규모는 2023년 55억 9,000만 달러로 평가되며, 2024년 57억 9,000만 달러에서 2032년 79억 7,000만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 3.5%의 CAGR로 성장할 것으로 예상됩니다.

전신 마취 시장은 수술 건수 증가와 새로운 마취제 도입으로 인해 크게 성장하고 있습니다. 전 세계적으로 매년 3억 1,000만 건의 대수술이 시행되고 있으며, 미용 및 재건 수술의 증가로 인해 특히 심혈관질환 및 만성 신장 질환을 앓고 있는 환자들을 위한 정맥 내(IV) 마취제에 대한 수요가 증가하고 있습니다. PainPass의 CBD/리도카인 라인과 Hikma Pharmaceuticals의 부피바카인 염산염 주사제와 같은 혁신적인 국소 마취제는 시장 확대에 더욱 기여하고 있습니다. 또한 PAION AG의 Byfavo와 같은 시술용 진정제의 규제 상황은 진화하는 상황을 보여주고 있습니다. 이러한 추세는 수술 건수와 제품 혁신 모두 지속적으로 증가하고 있는 전신 마취제 시장의 견조한 시장 추세를 보여줍니다.

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

전신 마취제 시장 규모 : 약물 유형별

전신 마취제 시장 규모 : 투여 경로별

전신 마취제 시장 규모 : 최종 용도별

전신 마취제 시장 규모 : 용도별

전신 마취제 시장 규모

경쟁 정보

주요 기업 개요

결론과 추천사항

ksm
영문 목차

영문목차

General Anesthesia Drugs Market size was valued at USD 5.59 Billion in 2023 and is poised to grow from USD 5.79 Billion in 2024 to USD 7.97 Billion by 2032, growing at a CAGR of 3.5% during the forecast period (2025-2032).

The general anaesthesia market is witnessing significant growth, primarily driven by the rising number of surgical procedures and the introduction of new anaesthetic medications. With 310 million major surgeries conducted globally each year and a notable increase in cosmetic and reconstructive procedures, the demand for intravenous (IV) anaesthetics is escalating, particularly for patients with cardiovascular and chronic renal diseases. Innovative local anaesthetic products, such as PainPass's CBD/lidocaine line and Hikma Pharmaceuticals' Bupivacaine HCl Injection, further contribute to market expansion. Additionally, regulatory approvals like PAION AG's Byfavo for procedural sedation demonstrate an evolving landscape. These trends indicate a robust market trajectory for general anaesthesia as both surgical volumes and product innovations continue to rise.

Top-down and bottom-up approaches were used to estimate and validate the size of the General Anesthesia Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

General Anesthesia Drugs Market Segmental Analysis

Global General Anesthesia Drugs Market is segmented by drug type, Route of Administration, end-use, application and region. Based on drug type, the market is segmented into propofol, sevoflurane, desflurane, ketamine, thiopental, etomidate and others. Based on route of administration, the market is segmented into intravenous and inhaled. Based on end-use, the market is segmented into hospitals, ambulatory surgical centers, clinics and others. Based on application, the market is segmented into cardiovascular surgery, orthopedic surgery, neurosurgery, general surgery, cosmetic surgery and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the General Anesthesia Drugs Market

The growth of the general anesthesia drugs market is significantly driven by the rising incidence of cancer in the United States. Recent estimates from the National Cancer Institute indicate that there are currently around 16.9 million cancer survivors, with projections suggesting this figure could reach 22.2 million by 2030. The prevalence of various cancers, including lung, breast, and prostate cancer, is increasing, which leads to a greater need for surgical interventions. As surgeries, particularly for malignant tumors, present the most effective treatment option when cancer is localized, the demand for general anesthesia is expected to rise correspondingly, propelling the market forward.

Restraints in the General Anesthesia Drugs Market

The General Anesthesia Drugs market faces significant restraint due to the associated risks in pediatric patients and pregnant women. Caution is paramount when administering general anesthetics to infants and young children, as their physiological responses differ from adults, influenced by aspects like body composition and the maturation of organ functions. Research has highlighted potential dangers, such as extensive nerve cell death in young animals following prolonged exposure to these drugs, leading to increased scrutiny within human studies. The FDA has further issued warnings about the risks of prolonged or repeated use in children under three and pregnant women, leading healthcare providers to reconsider the adoption of these anesthetic treatments, which may hinder market growth.

Market Trends of the General Anesthesia Drugs Market

The General Anesthesia Drugs market is witnessing significant growth, driven by intensive research and development efforts aimed at enhancing clinical outcomes and patient recovery. Notable studies, such as those from the University of Michigan and Washington University School of Medicine, are assessing the efficacy of existing anesthetics, including inhaled agents and intravenous propofol, to refine usage protocols. This focus on evidence-based practice is poised to improve patient care, making anesthetics safer and more effective. As a result, the market is likely to expand, fueled by innovations that meet the increasing demands of surgical procedures and patient safety standards throughout the forecast period.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global General Anesthesia Drugs Market Size by Drug Type & CAGR (2025-2032)

Global General Anesthesia Drugs Market Size by Route of Administration & CAGR (2025-2032)

Global General Anesthesia Drugs Market Size by End-Use & CAGR (2025-2032)

Global General Anesthesia Drugs Market Size by Application & CAGR (2025-2032)

Global General Anesthesia Drugs Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기